Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Mehta Vimal Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 21,988 shares @ $21.41, valued at $470.8k
Sold 8,012 shares @ $21.9, valued at $175.5k
Sold 24,987 shares @ $20.01, valued at $500k
Sold 4,266 shares @ $20.9, valued at $89.2k
Sold 747 shares @ $21.89, valued at $16.4k
Exercised 2,609 restricted stock units @ $0
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
05/24/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 6,500 shares @ $25.7909, valued at $167.6k
05/16/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Exercised 15,000 restricted stock units @ $0
03/22/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 24,667 shares @ $18.2, valued at $448.9k
Sold 5,333 shares @ $18.86, valued at $100.6k
Sold 3,896 shares @ $18.22, valued at $71k
Sold 604 shares @ $18.88, valued at $11.4k
Sold 29,100 shares @ $19.7, valued at $573.3k
Sold 900 shares @ $20.15, valued at $18.1k
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
03/16/2023 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Exercised 10,437 restricted stock units @ $0
Granted 56,000 restricted stock units @ $0
Granted 168,000 options to buy @ $19.6, valued at $3.3M
12/19/2022 4 Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 22,794 shares @ $19.86, valued at $452.7k
Sold 7,206 shares @ $20.19, valued at $145.5k
Sold 20,113 shares @ $19.21, valued at $386.4k
Sold 9,887 shares @ $19.92, valued at $196.9k
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
Exercised 30,000 options to buy @ $0.41, valued at $12.3k
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2021 4 Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Sold 473,250 shares @ $30.8283, valued at $14.6M
03/29/2021 4 Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 250,000 options to buy @ $41.17, valued at $10.3M
05/28/2020 4 Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 250,000 options to buy @ $45.99, valued at $11.5M
05/13/2020 4 Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Disposed/sold 300,000 shares @ $30.08, valued at $9M
08/19/2019 4 Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Bought 974 shares @ $8.89, valued at $8.7k
08/16/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2019 4 Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Granted 187,700 options to buy @ $10.04, valued at $1.9M
12/14/2018 4 Mehta Vimal (CEO, President, Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Bought 800 shares @ $4.27, valued at $3.4k
Bought 200 shares @ $4.32, valued at $864
Bought 500 shares @ $4.48, valued at $2.2k
Bought 400 shares @ $4.49, valued at $1.8k
Bought 100 shares @ $4.5, valued at $450
12/04/2018 4 Mehta Vimal (CEO, President, Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Bought 500 shares @ $5.09, valued at $2.5k
Bought 500 shares @ $5.15, valued at $2.6k
12/04/2018 4 Mehta Vimal (CEO, President, Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Bought 200 shares @ $5.1, valued at $1k
Bought 100 shares @ $5.13, valued at $513
Bought 100 shares @ $5.14, valued at $514
Bought 100 shares @ $5.18, valued at $518
Bought 500 shares @ $5.2, valued at $2.6k
11/30/2018 4 Mehta Vimal (CEO, President, Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.
Txns: Bought 300 shares @ $5.04, valued at $1.5k
Bought 300 shares @ $5.05, valued at $1.5k
Bought 100 shares @ $5.17, valued at $517
Bought 300 shares @ $5.2, valued at $1.6k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy